Benefit of Probiotics on Cardiovascular Health- A Narrative Review
Coronary artery disease (CAD) is a leading cause of death globally and a prevalent cardiovascular disease (CVD) in which plaque buildup in artery walls results in inadequate blood flow. Risk factors for CAD include hypertension, inflammation, diabetes, and poor diet. In the past few decades, research has emerged on the employment of probiotics in cardiovascular health, particularly focused on methods for using probiotics as preventative measures for the risk factors of CAD. Probiotics can reduce hypertension and inflammation, improve insulin sensitivity, and possibly reduce salt levels in individuals with high-sodium diets. Still, more research needs to be done on the safety and considerations of administering probiotics and their underlying mechanisms since the evidence is predominantly experimental. Probiotics have proven to be a valuable research point given the urgency and incidence rates of coronary artery disease.
1. What is coronary heart disease? U.S. Department of Health and Human Services. Accessed June 20,2024.https://www.nhlbi.nih.gov/health/coronary-heart-disease
2. Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics.J Cell Physiol.2019;234(10):16812-16823.doi:10.1002/icp.28350
3. Regmi M, Siccardi MA. Coronary Artery Disease Prevention. In: StatPearls[Internet]. StatPearls Publishing;2023.https://www.ncbi.nlm.nih.gov/books/NBK547760/
4. Duggan JP, Peters AS, Trachiotis GD, Antevil JL.Epidemiology of Coronary Artery Disease. Surg Clin North Am.2022;102(3):499-516. doi:10.1016/j.suc.2022.01.007
5. Malakar AK, Choudhury D, Halder B, Paul P, Uddin A,Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol.2019;234(10):16812-16823.doi:10.1002/jcp.28350
6. Williams NT. Probiotics. Am J Health Syst Pharm.2010;67(6):449-458.doi:10.2146/ajhp090168
7. Gasbarrini G, Bonvicini F, Gramenzi A. Probiotics History. J Clin Gastroenterol. 2016;50(Suppl 2):S116-S119. doi:10.1097/MCG.0000000000000697
8. Oniszczuk A, Oniszczuk T, Gancarz M, Szymáska J. Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular Diseases. Molecules.2021;26(4):1172. doi:10.3390/molecules26041172
9. Christodoulidis G, Vittorio TJ, Fudim M, Lerakis S,Kosmas CE. Inflammation in coronary artery disease.Cardiol Rev.2014;22(6):279-288. doi:10.1097/CRD.0000000000000006
10. Wu H, Chiou J. Potential Benefits of Probiotics and Prebiotics for Coronary Heart Disease and Stroke.Nutrients.2021;13(8):2878.doi:10.3390/nu13082878
11. Trudeau F, Gilbert K, Tremblay A, Tompkins TA,Godbout R, Rousseau G. Bifidobacterium longum R0175 attenuates post-myocardial infarction depressive-like behaviour in rats. PLoS One.2019;14(4):e0215101.doi:10.1371/journal.pone.0215101
12. Medina M, De Palma G, Ribes-Koninckx C,Calabuig M, Sanz Y. Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients.J Inflamm(Lond).2008;5:19. doi:10.1186/1476-9255-5-19
13. Park S,Kang J,Choi S,et al. Cholesterol-lowering effect of Lactobacillus rhamnosus BFE5264 and its influence on the gut microbiome and propionate level in a murine model. PLoS One. 2018;13(8):e0203150.doi:10.1371/journal.pone.0203150
14. Abdi M, Esmaeili Gouvarchin Ghaleh H, Ranjbar R. Lactobacilli and Bifidobacterium as anti-atherosclerotic agents. Iran J Basic Med Sci.2022;25(8):934-946. doi:10.22038/IJBMS.2022.63860.14073
15. Peng K, Li X, Wang Z, Li M, Yang Y. Association of low-density lipoprotein cholesterol levels with the risk of mortality and cardiovascular events: A meta-analysis of cohort studies with 1,232,694 participants. Medicine(Baltimore).2022;101(48):e32003. doi:10.1097/MD.0000000000032003
16. Momin ES, Khan AA, Kashyap T, et al. The Effects of Probiotics on Cholesterol Levels in Patients With Metabolic Syndrome: A Systematic Review. Cureus.2023;15(4):e37567. doi:10.7759/cureus.37567
17. Puttarat N, Kasorn A, Vitheejongjaroen P,Chantarangkul C, Tangwattanachuleeporn M,Taweechotipatr M. Beneficial Effects of Indigenous Probiotics in High-Cholesterol Diet-Induced Hypercholesterolemic Rats. Nutrients.2023;15(12):2710.doi:10.3390/nu15122710
18. Konukoglu D, Uzun H. Endothelial dysfunction and hypertension. Advances in Experimental Medicine and Biology. Published online 2016:511-540.doi:10.1007/5584_2016_90
19. Herman LL, Padala SA, Ahmed I, Bashir K.Angiotensin-Converting Enzyme Inhibitors(ACEI).In: StatPearls[Internet]. StatPearls Publishing; 2023.https://pubmed.ncbi.nlm.nih.gov/28613705/
20. Gütiez L, Gómez-Sala B, Recio I, et al.Enterococcus faecalis strains from food,environmental, and clinical origin produce ACE-inhibitory peptides and other bioactive peptides during growth in bovine skim milk. Int J Food Microbiol.2013;166(1):93-101.doi:10.1016/j.ijfoodmicro.2013.06.019
21. Rehman HU, Nasir M, Abdul Jabbar M, et al. Bio-therapeutics effects of probiotic strain on the gastrointestinal health of severely acute malnourished children. Cell Mol Biol(Noisy-le-grand).2020;66(4):65-72. doi:10.14715/cmb/2020.66.4.11
22. Jia S, Liu Y, Yuan J. Evidence in Guidelines for Treatment of Coronary Artery Disease. Adv Exp Med Biol.2020;1177:37-73. doi:10.1007/978-981-15-2517-9 2
23.Liu E,Bigeh A, Ledingham L, Mehta L. Prevention of Coronary Artery Disease in Women. Curr Cardiol Rep.2022;24(8):1041-1048. doi:10.1007/s11886-022-01721-5
24.Sales BIM, Cioffi D, Ferreira SRG. Probiotics supplementation and insulin resistance: a systematic review. Diabetol Metab Syndr.2020;12(1):98.doi:10.1186/s13098-020-00603-6
25. Muniyappa R, Sowers JR. Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord.2013;14(1):5-12. doi:10.1007/s11154-012-9229-1
26.Zhou W,Cheng Y,Zhu P,Nasser MI,Zhang X,Zhao M. Implication of Gut Microbiota in Cardiovascular Diseases. Oxid Med Cell Longev.2020;2020:5394096. doi:10.1155/2020/5394096
27.Kim YA, Keogh JB,Clifton PM. Probiotics,prebiotics, synbiotics and insulin sensitivity. Nutr Res Rev.2018;31(1):35-51. doi:10.1017/S095442241700018X
28.Kwofie MK, Bukari N, Adeboye O. Probiotics potential of yeast and lactic acid bacteria fermented foods and the impact of processing: A review of Indigenous and Continental Food Products. Advances in Microbiology.2020;10(09):492-507. doi:10.4236/aim.2020.109037
29.Siddiqui SA,Erol Z, Rugji J,Tasq F,Kahraman HA, Toppi V, et al. An overview of fermentation in the food industry- looking back from a new perspective. Bioresources and Bioprocessing.2023;10(1).doi:10.1186/s40643-023-00702-y
30. Zawistowska-Rojek A, Tyski S. Are Probiotic Really Safe for Humans? Pol J Microbiol.2018;67(3):251-258. doi:10.21307/pjm-2018-044
31.Suez J,Zmora N,Segal E,Elinav E.The pros,cons,and many unknowns of probiotics. Nat Med.2019;25(5):716-729. doi:10.1038/s41591-019-0439-x